Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	prolactin receptor binding	GH1 CSH1 CSH2 CSHL1	3.54e-07	7	203	4	GO:0005148
GeneOntologyMolecularFunction	growth hormone receptor binding	GH1 CSH1 CSH2 CSHL1	2.08e-06	10	203	4	GO:0005131
GeneOntologyBiologicalProcess	positive regulation of steroid hormone biosynthetic process	GH1 CSH1 CSH2 CSHL1	6.08e-06	13	203	4	GO:0090031
GeneOntologyBiologicalProcess	positive regulation of multicellular organism growth	ATP8A2 TSHR GH1 CSH1 CSH2 CSHL1	6.48e-06	47	203	6	GO:0040018
GeneOntologyBiologicalProcess	positive regulation of hormone biosynthetic process	GH1 CSH1 CSH2 CSHL1	3.14e-05	19	203	4	GO:0046886
GeneOntologyBiologicalProcess	positive regulation of steroid biosynthetic process	GH1 SCP2 CSH1 CSH2 CSHL1	3.39e-05	38	203	5	GO:0010893
GeneOntologyBiologicalProcess	positive regulation of D-glucose transmembrane transport	ERBB4 GH1 GPC3 CSH1 CSH2 CSHL1	3.60e-05	63	203	6	GO:0010828
GeneOntologyBiologicalProcess	positive regulation of steroid metabolic process	GH1 SCP2 CSH1 CSH2 CSHL1	5.56e-05	42	203	5	GO:0045940
GeneOntologyBiologicalProcess	regulation of D-glucose transmembrane transport	ERBB4 GH1 GPC3 EDNRA CSH1 CSH2 CSHL1	8.13e-05	105	203	7	GO:0010827
GeneOntologyBiologicalProcess	regulation of steroid hormone biosynthetic process	GH1 CSH1 CSH2 CSHL1	8.29e-05	24	203	4	GO:0090030
GeneOntologyBiologicalProcess	regulation of steroid biosynthetic process	GH1 PEX2 SCP2 APOB CSH1 CSH2 CSHL1	8.63e-05	106	203	7	GO:0050810
GeneOntologyBiologicalProcess	regulation of response to nutrient levels	GH1 CSH1 CSH2 CSHL1 MTOR	8.68e-05	46	203	5	GO:0032107
GeneOntologyBiologicalProcess	D-glucose transmembrane transport	ERBB4 GH1 GPC3 PPARD EDNRA CSH1 CSH2 CSHL1	1.11e-04	148	203	8	GO:1904659
GeneOntologyBiologicalProcess	growth hormone receptor signaling pathway	GH1 CSH1 CSH2 CSHL1	1.15e-04	26	203	4	GO:0060396
GeneOntologyBiologicalProcess	positive regulation of hormone metabolic process	GH1 CSH1 CSH2 CSHL1	1.15e-04	26	203	4	GO:0032352
GeneOntologyBiologicalProcess	hexose transmembrane transport	ERBB4 GH1 GPC3 PPARD EDNRA CSH1 CSH2 CSHL1	1.28e-04	151	203	8	GO:0008645
GeneOntologyBiologicalProcess	cellular response to growth hormone stimulus	GH1 CSH1 CSH2 CSHL1	1.34e-04	27	203	4	GO:0071378
GeneOntologyBiologicalProcess	monosaccharide transmembrane transport	ERBB4 GH1 GPC3 PPARD EDNRA CSH1 CSH2 CSHL1	1.47e-04	154	203	8	GO:0015749
GeneOntologyBiologicalProcess	chromosome organization	ANKRD31 MCM8 SMC1A NBN BUB1B SHOC1 SPATA22 TOP1MT ANAPC5 CUL3 SHLD1 MSH4 TEX15 GOLGA8H SENP6 KDM4A TOP1 SMC1B	1.58e-04	686	203	18	GO:0051276
GeneOntologyBiologicalProcess	regulation of lipid biosynthetic process	ERBB4 GH1 BRCA1 PEX2 SCP2 APOB CSH1 CSH2 CSHL1 MTOR	1.70e-04	246	203	10	GO:0046890
GeneOntologyBiologicalProcess	inner ear receptor cell stereocilium organization	GRXCR1 TSHR TRIP11 OTOGL FAT4	1.72e-04	53	203	5	GO:0060122
GeneOntologyBiologicalProcess	positive regulation of lipid biosynthetic process	ERBB4 GH1 SCP2 CSH1 CSH2 CSHL1 MTOR	1.98e-04	121	203	7	GO:0046889
GeneOntologyBiologicalProcess	positive regulation of lipid metabolic process	ERBB4 GH1 SCP2 PPARD CSH1 CSH2 CSHL1 MTOR	2.35e-04	165	203	8	GO:0045834
GeneOntologyBiologicalProcess	response to food	GH1 CSH1 CSH2 CSHL1 MTOR	2.64e-04	58	203	5	GO:0032094
GeneOntologyBiologicalProcess	positive regulation of receptor signaling pathway via JAK-STAT	ERBB4 GH1 CSH1 CSH2 CSHL1	2.64e-04	58	203	5	GO:0046427
GeneOntologyBiologicalProcess	carbohydrate transmembrane transport	ERBB4 GH1 GPC3 PPARD EDNRA CSH1 CSH2 CSHL1	2.66e-04	168	203	8	GO:0034219
GeneOntologyBiologicalProcess	homologous chromosome pairing at meiosis	ANKRD31 SHOC1 SPATA22 MSH4 TEX15	3.09e-04	60	203	5	GO:0007129
GeneOntologyBiologicalProcess	regulation of multicellular organism growth	ATP8A2 TSHR GH1 CSH1 CSH2 CSHL1	3.16e-04	93	203	6	GO:0040014
GeneOntologyBiologicalProcess	regulation of steroid metabolic process	GH1 PEX2 SCP2 APOB CSH1 CSH2 CSHL1	3.86e-04	135	203	7	GO:0019218
GeneOntologyCellularComponent	growth hormone receptor complex	GH1 CSH1 CSH2 CSHL1	1.41e-07	6	208	4	GO:0070195
MousePheno	decreased pituitary gland weight	GH1 CSH1 CSH2 CSHL1	1.26e-06	8	165	4	MP:0008938
MousePheno	absent somatotrophs	GH1 CSH1 CSH2 CSHL1	2.25e-06	9	165	4	MP:0008330
MousePheno	absent lactotrophs	GH1 CSH1 CSH2 CSHL1	2.25e-06	9	165	4	MP:0008333
MousePheno	increased circulating ghrelin level	GH1 CSH1 CSH2 CSHL1	8.61e-06	12	165	4	MP:0011612
MousePheno	abnormal pituitary gland weight	GH1 CSH1 CSH2 CSHL1	8.61e-06	12	165	4	MP:0008937
MousePheno	abnormal circulating ghrelin level	GH1 CSH1 CSH2 CSHL1	2.31e-05	15	165	4	MP:0011611
MousePheno	decreased lactotroph cell number	GH1 CSH1 CSH2 CSHL1	3.95e-05	17	165	4	MP:0008332
MousePheno	abnormal lactotroph morphology	GH1 CSH1 CSH2 CSHL1	6.32e-05	19	165	4	MP:0008323
MousePheno	decreased somatotroph cell number	GH1 CSH1 CSH2 CSHL1	9.58e-05	21	165	4	MP:0008329
MousePheno	hypothalamus hyperplasia	CUL3 APAF1	1.38e-04	2	165	2	MP:0000839
MousePheno	small adenohypophysis	GH1 CSH1 CSH2 CSHL1	1.39e-04	23	165	4	MP:0008321
MousePheno	abnormal somatotroph morphology	GH1 CSH1 CSH2 CSHL1	1.65e-04	24	165	4	MP:0008322
Domain	SOMATOTROPIN_2	GH1 CSH1 CSH2 CSHL1	1.96e-07	6	202	4	PS00338
Domain	SOMATOTROPIN_1	GH1 CSH1 CSH2 CSHL1	1.96e-07	6	202	4	PS00266
Domain	Hormone_1	GH1 CSH1 CSH2 CSHL1	1.96e-07	6	202	4	PF00103
Domain	Somatotropin	GH1 CSH1 CSH2 CSHL1	4.53e-07	7	202	4	IPR001400
Domain	Somatotropin_CS	GH1 CSH1 CSHL1	1.23e-05	5	202	3	IPR018116
Domain	ACTININ_2	DST FLNB SYNE1 LCP1	1.00e-04	23	202	4	PS00020
Domain	ACTININ_1	DST FLNB SYNE1 LCP1	1.00e-04	23	202	4	PS00019
Domain	Actinin_actin-bd_CS	DST FLNB SYNE1 LCP1	1.00e-04	23	202	4	IPR001589
Domain	DNA_brk_join_enz	TOP1MT TOP1	1.16e-04	2	202	2	IPR011010
Domain	TopoI_cat_a/b-sub_euk	TOP1MT TOP1	1.16e-04	2	202	2	IPR014727
Domain	TopoI	TOP1MT TOP1	1.16e-04	2	202	2	IPR001631
Domain	TopoI_cat_a-hlx-sub_euk	TOP1MT TOP1	1.16e-04	2	202	2	IPR014711
Domain	TopoI_C_dom	TOP1MT TOP1	1.16e-04	2	202	2	IPR025834
Domain	-	TOP1MT TOP1	1.16e-04	2	202	2	1.10.132.10
Domain	-	AP2A1 AP2A2	1.16e-04	2	202	2	2.60.40.1030
Domain	Topoisom_I	TOP1MT TOP1	1.16e-04	2	202	2	PF01028
Domain	TopoI_AS	TOP1MT TOP1	1.16e-04	2	202	2	IPR018521
Domain	DNA_topo_domain1	TOP1MT TOP1	1.16e-04	2	202	2	IPR013034
Domain	Clathrin_a-adaptin_app_Ig-like	AP2A1 AP2A2	1.16e-04	2	202	2	IPR013038
Domain	TopoI_DNA-bd_mixed-a/b_euk	TOP1MT TOP1	1.16e-04	2	202	2	IPR013030
Domain	-	TOP1MT TOP1	1.16e-04	2	202	2	1.10.10.41
Domain	TopoI_euk	TOP1MT TOP1	1.16e-04	2	202	2	IPR013499
Domain	-	TOP1MT TOP1	1.16e-04	2	202	2	2.170.11.10
Domain	Topo_C_assoc	TOP1MT TOP1	1.16e-04	2	202	2	PF14370
Domain	Topoisom_I_N	TOP1MT TOP1	1.16e-04	2	202	2	PF02919
Domain	TOPEUc	TOP1MT TOP1	1.16e-04	2	202	2	SM00435
Domain	TopoI_cat_euk	TOP1MT TOP1	1.16e-04	2	202	2	IPR013500
Domain	TopoI_DNA-bd_euk	TOP1MT TOP1	1.16e-04	2	202	2	IPR008336
Domain	-	TOP1MT TOP1	1.16e-04	2	202	2	3.90.15.10
Domain	AP2_complex_asu	AP2A1 AP2A2	1.16e-04	2	202	2	IPR017104
Domain	Clathrin_a-adaptin_app_sub_C	AP2A1 AP2A2	1.16e-04	2	202	2	IPR003164
Domain	Alpha_adaptin_C	AP2A1 AP2A2	1.16e-04	2	202	2	PF02296
Domain	TOPOISOMERASE_I_EUK	TOP1MT TOP1	1.16e-04	2	202	2	PS00176
Domain	Ig_I-set	MYOM1 LRIG2 IGSF10 SEMA3C FLT1 SDK2 ADAMTSL3 HMCN1 IGSF9B	2.31e-04	190	202	9	IPR013098
Domain	I-set	MYOM1 LRIG2 IGSF10 SEMA3C FLT1 SDK2 ADAMTSL3 HMCN1 IGSF9B	2.31e-04	190	202	9	PF07679
Domain	CH	DST EHBP1 FLNB SYNE1 LCP1	6.87e-04	65	202	5	SM00033
Domain	TRPM_tetra	TRPM6 TRPM1	6.88e-04	4	202	2	PF16519
Domain	GLTP	PLEKHA8 PLEKHA8P1	6.88e-04	4	202	2	PF08718
Domain	Clathrin_a/coatomer_app_sub_C	AP2A1 AP2A2	6.88e-04	4	202	2	IPR015873
Domain	Glycolipid_transfer_prot_dom	PLEKHA8 PLEKHA8P1	6.88e-04	4	202	2	IPR014830
Domain	TRPM_tetra	TRPM6 TRPM1	6.88e-04	4	202	2	IPR032415
Domain	-	AP2A1 AP2A2	6.88e-04	4	202	2	3.30.310.30
Domain	CH	DST EHBP1 FLNB SYNE1 LCP1	9.64e-04	70	202	5	PF00307
Domain	-	DST EHBP1 FLNB SYNE1 LCP1	1.03e-03	71	202	5	1.10.418.10
Domain	BRCT	NBN BRCA1 REV1	1.06e-03	19	202	3	PF00533
Domain	Anaphylatoxin_comp_syst	C4A C4B	1.14e-03	5	202	2	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B	1.14e-03	5	202	2	IPR001840
Domain	SMC	SMC1A SMC1B	1.14e-03	5	202	2	IPR024704
Domain	CH	DST EHBP1 FLNB SYNE1 LCP1	1.17e-03	73	202	5	PS50021
Domain	CH-domain	DST EHBP1 FLNB SYNE1 LCP1	1.32e-03	75	202	5	IPR001715
Domain	BRCT	NBN BRCA1 REV1	1.65e-03	22	202	3	SM00292
Domain	SMC_hinge	SMC1A SMC1B	1.70e-03	6	202	2	SM00968
Domain	SMC_hinge	SMC1A SMC1B	1.70e-03	6	202	2	PF06470
Domain	SMC_hinge	SMC1A SMC1B	1.70e-03	6	202	2	IPR010935
Domain	-	NBN BRCA1 REV1	1.88e-03	23	202	3	3.40.50.10190
Pathway	REACTOME_PROLACTIN_RECEPTOR_SIGNALING	GH1 CSH1 CSH2 CSHL1	1.00e-05	13	158	4	MM14516
Pathway	BIOCARTA_TFF_PATHWAY	GH1 APAF1 CSH1 CSH2 CSHL1	1.59e-05	29	158	5	MM1522
Pathway	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	GH1 CSH1 CSH2 CSHL1	2.49e-05	16	158	4	MM15710
Pathway	BIOCARTA_LONGEVITY_PATHWAY	GH1 CSH1 CSH2 CSHL1	5.16e-05	19	158	4	MM1513
Pathway	REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN	GH1 CSH1 CSH2 CSHL1	6.40e-05	20	158	4	MM15070
Pathway	BIOCARTA_AKT_PATHWAY	GH1 CSH1 CSH2 CSHL1	1.87e-04	26	158	4	MM1345
Pathway	WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME	SMC1A NBN BRCA1	2.13e-04	11	158	3	M42562
Pubmed	microRNA-449a reduces growth hormone-stimulated senescent cell burden through PI3K-mTOR signaling.	GH1 CSH1 CSH2 CSHL1 MTOR	1.59e-10	7	210	5	36976763
Pubmed	The rapid activation of protein synthesis by growth hormone requires signaling through mTOR.	GH1 CSH1 CSH2 CSHL1 MTOR	1.59e-10	7	210	5	17284572
Pubmed	Growth hormone and insulin-like growth factor-I enhance beta-glucuronidase gene activation by androgen in mouse kidney.	GH1 CSH1 CSH2 CSHL1 GUSB	4.22e-10	8	210	5	10459853
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	SMC1A NBN MDN1 AP2A1 BRCA1 AP2A2 MGA REV1 RBM15 SUPT20H SUPT16H SENP6 LRIF1	1.15e-09	222	210	13	37071664
Pubmed	Central growth hormone action regulates metabolism during pregnancy.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	31479305
Pubmed	Molecular evolution of growth hormone and receptor in the guinea-pig, a mammal unresponsive to growth hormone.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	10767558
Pubmed	Rescue of pituitary function in a mouse model of isolated growth hormone deficiency type II by RNA interference.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	18006625
Pubmed	Body composition of inactivated growth hormone (oMt1a-oGH) transgenic mice: generation of an obese phenotype.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	9546108
Pubmed	Glucose homeostasis and insulin sensitivity in growth hormone-transgenic mice: a cross-sectional analysis.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	20707609
Pubmed	Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	10810296
Pubmed	Somatotropin transgenic mice have reduced jejunal active glucose transport rates.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	7965203
Pubmed	Pleiotropic effects of growth hormone signaling in aging.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	21852148
Pubmed	Body composition, bone mass and microstructural analysis in GH-transgenic mice reveals that skeletal changes are specific to bone compartment and gender.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	12175649
Pubmed	Transgenic mice reveal novel activities of growth hormone in wound repair, angiogenesis, and myofibroblast differentiation.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	15070902
Pubmed	A novel missense mutation in the mouse growth hormone gene causes semidominant dwarfism, hyperghrelinemia, and obesity.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	14726450
Pubmed	UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	24758742
Pubmed	Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	10594738
Pubmed	Age-related changes in body composition of bovine growth hormone transgenic mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	18948397
Pubmed	Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	8496314
Pubmed	Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	15616010
Pubmed	Nitric oxide stimulates embryonic somatotroph differentiation and growth hormone mRNA and protein expression through a cyclic guanosine monophosphate-independent mechanism.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	19019400
Pubmed	Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	11346667
Pubmed	Cardiac contractile function is enhanced in isolated ventricular myocytes from growth hormone transgenic mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	12010633
Pubmed	Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	17626886
Pubmed	Regulation of rapid signal transducer and activator of transcription-5 phosphorylation in the resting cells of the growth plate and in the liver by growth hormone and feeding.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	19359380
Pubmed	Involvement of insulin-like growth factor-1 in the effect of caloric restriction: regulation of plasma adiponectin and leptin.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	17301034
Pubmed	Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	17242167
Pubmed	A single injection of double-stranded adeno-associated viral vector expressing GH normalizes growth in GH-deficient mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	18180319
Pubmed	Cloning and characterisation of the GH gene from the common dolphin (Delphinus delphis).	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	12225773
Pubmed	Effect of genetic background on growth of mice hemizygous for wild-type or dwarf mutated bovine growth hormone transgenes.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	24190208
Pubmed	Promotion of Joint Degeneration and Chondrocyte Metabolic Dysfunction by Excessive Growth Hormone in Mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	36762426
Pubmed	High molecular weight isoforms of growth hormone in cells of the immune system.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	21741628
Pubmed	Thiol-Disulfide Exchange in Human Growth Hormone.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	26887678
Pubmed	The role of growth hormone in fetal mouse reproductive tract differentiation.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	8756530
Pubmed	Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	17881271
Pubmed	Growth hormone production and action in N1E-115 neuroblastoma cells.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	19301152
Pubmed	Transgenic mice overexpressing growth hormone (GH) have reduced or increased cardiac apoptosis through activation of multiple GH-dependent or -independent cell death pathways.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	18617616
Pubmed	Promoter shuffling has occurred during the evolution of the vertebrate growth hormone gene.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	10974531
Pubmed	Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	23428905
Pubmed	Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	17761891
Pubmed	Growth hormone prevents the development of autoimmune diabetes.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	24218587
Pubmed	Transgene transmission to progeny by oMt1a-oGH transgenic mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	16201410
Pubmed	Genes that prolong life: relationships of growth hormone and growth to aging and life span.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	11487592
Pubmed	Overexpressed growth hormone (GH) synergistically promotes carcinogen-initiated liver tumour growth by promoting cellular proliferation in emerging hepatocellular neoplasms in female and male GH-transgenic mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	11318985
Pubmed	Identification of the glomerular podocyte as a target for growth hormone action.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	17272398
Pubmed	Induction of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	1874564
Pubmed	Growth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	32100023
Pubmed	Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	17347312
Pubmed	Consequences of overexpression of growth hormone in transgenic mice on liver cytochrome P450 enzymes.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	10076541
Pubmed	Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	23639351
Pubmed	Pituitary growth hormone network responses are sexually dimorphic and regulated by gonadal steroids in adulthood.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	21098290
Pubmed	Exploring endocrine GH pattern in mice using rank plot analysis and random blood samples.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	21045135
Pubmed	Analysis of gender difference of cardiac risk biomarkers using hGH-transgenic mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	16508206
Pubmed	The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH?	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	32556100
Pubmed	High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	1525063
Pubmed	Growth hormone stimulates the selective trafficking of thymic CD4+CD8- emigrants to peripheral lymphoid organs.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	15316240
Pubmed	Growth hormone action in the developing neural retina: a proteomic analysis.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	18203262
Pubmed	Assignment of the porcine growth hormone gene to chromosome 12.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	2249485
Pubmed	The related genes encoding growth hormone and prolactin have been dispersed to chromosomes 10 and 17 in the rat.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	3780533
Pubmed	High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	10395045
Pubmed	Brief report: short stature caused by a mutant growth hormone.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	8552145
Pubmed	Structure of the growth hormone-encoding gene and its promoter in mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	8647448
Pubmed	GH Knockout Mice Have Increased Subcutaneous Adipose Tissue With Decreased Fibrosis and Enhanced Insulin Sensitivity.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	31099824
Pubmed	Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	1980158
Pubmed	Neural growth hormone implicated in body weight sex differences.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	23861378
Pubmed	Growth hormone increases low-density lipoprotein receptor and HMG-CoA reductase mRNA expression in mesangial cells.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	12759574
Pubmed	Adipocyte insensitivity to insulin in growth hormone-transgenic mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	11350075
Pubmed	Growth hormone and fertility in oMt1a-oGH transgenic mice.	GH1 CSH1 CSH2 CSHL1	6.43e-09	5	210	4	11570960
Pubmed	GH modulates hepatic epidermal growth factor signaling in the mouse.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	20032199
Pubmed	Third party data gene data set of eutherian growth hormone genes.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	26697363
Pubmed	Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	15985453
Pubmed	Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	16141391
Pubmed	Sex differences in thrombosis in mice are mediated by sex-specific growth hormone secretion patterns.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	18618017
Pubmed	Evidence that growth hormone exerts a feedback effect on stomach ghrelin production and secretion.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	14530511
Pubmed	Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	21849508
Pubmed	Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	14702113
Pubmed	Systemic over-secretion of growth hormone in transgenic mice results in a specific pattern of skeletal modeling and adaptation.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	9556071
Pubmed	Transgenic studies with a keratin promoter-driven growth hormone transgene: prospects for gene therapy.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	8990189
Pubmed	Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	15138153
Pubmed	Growth Hormone (GH) Deficient Mice With GHRH Gene Ablation Are Severely Deficient in Vaccine and Immune Responses Against Streptococcus pneumoniae.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	30333823
Pubmed	The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	23349524
Pubmed	The use of transgenic mice to analyze the role of accessory factor two in the regulation of phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	11309401
Pubmed	Genetic dissection of IGF1-dependent and -independent effects of permanent GH excess on postnatal growth and organ pathology of mice.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	25017732
Pubmed	Role of growth hormone in the genetic change of mice divergently selected for body weight and fatness.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	10689811
Pubmed	Growth Hormone Pulses and Liver Gene Expression Are Differentially Regulated by the Circadian Clock Gene Bmal1.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	33539533
Pubmed	Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	20231469
Pubmed	Transcript abundance in mouse pituitaries with altered growth hormone expression quantified by reverse transcriptase polymerase chain reaction implicates transcription factor Zn-16 in gene regulation in vivo.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	12166626
Pubmed	Growth hormone expression in murine bone marrow cells is independent of the pituitary transcription factor Pit-1.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	9275086
Pubmed	Age related changes in gene expression within the cochlea of C57BL/6J mice.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	23010755
Pubmed	Growth hormone acts on liver to stimulate autophagy, support glucose production, and preserve blood glucose in chronically starved mice.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	30910968
Pubmed	Interactions of ghrelin signaling pathways with the GH neuroendocrine axis: a new and experimentally tested model.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	19433492
Pubmed	Enlargement of interscapular brown adipose tissue in growth hormone antagonist transgenic and in growth hormone receptor gene-disrupted dwarf mice.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	12563029
Pubmed	Growth hormone is necessary for the p53-mediated, obesity-induced insulin resistance in male C57BL/6J x CBA mice.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	23913444
Pubmed	Specific interactions of growth hormone (GH) with GH-receptors and GH-binding proteins in vivo in genetically GH-deficient Ames dwarf mice.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	10984300
Pubmed	Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	10467223
Pubmed	Role of SOCS2 in growth hormone actions.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	15734145
Pubmed	RASSF10 regulates bone invasion of growth hormone-secreting adenomas via exosomes.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	32423821
Pubmed	Effect of Deletion of Ghrelin-O-Acyltransferase on the Pulsatile Release of Growth Hormone in Mice.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	26442444
Pubmed	Growth hormone (GH)-transgenic insulin-like growth factor 1 (IGF1)-deficient mice allow dissociation of excess GH and IGF1 effects on glomerular and tubular growth.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	26997624
Pubmed	Growth hormone is increased in the lungs and enhances experimental lung metastasis of melanoma in DJ-1 KO mice.	GH1 CSH1 CSH2 CSHL1	1.92e-08	6	210	4	27825319
Interaction	MSH2 interactions	MCM8 SMC1A NBN PFDN4 ALDH1L1 BRCA1 REV1 PMS1 CUL3 ZNF510 PRPF8 VIRMA SUPT16H TOP1	3.96e-06	313	204	14	int:MSH2
Interaction	MSH6 interactions	MCM8 SMC1A NBN BIRC6 RUSC2 FBXO25 BRCA1 PMS1 CUL3 RIOK1 VIRMA SUPT16H TOP1	4.15e-06	271	204	13	int:MSH6
Interaction	KDM1A interactions	ZFYVE16 BIRC6 DST BRCA1 FAM161A SRGAP3 SPZ1 BUB1B SPATA22 KIF5B MGA NPAT CUL3 EHBP1 FLNB RIOK1 USP24 ZFP28 BIRC2 PPARD TEX9 THOC2 VIRMA TXNIP SUPT16H	1.04e-05	941	204	25	int:KDM1A
Interaction	CSH2 interactions	GH1 CSH1 CSH2 CSHL1	1.28e-05	15	204	4	int:CSH2
Interaction	GH1 interactions	GH1 FAM161A CSH1 CSH2	1.69e-05	16	204	4	int:GH1
Interaction	NUP43 interactions	SMC1A MAK16 CCDC168 CACTIN DST ATP8A1 BRCA1 PRRC2C RBM19 BUB1B CCSER2 KIF5B MGA NPAT RBM15 VIRMA SUPT16H SENP6 TOP1	2.11e-05	625	204	19	int:NUP43
Interaction	CSH1 interactions	GH1 CSH1 CSH2 CSHL1	2.79e-05	18	204	4	int:CSH1
Interaction	CSHL1 interactions	CSH1 CSH2 CSHL1	3.47e-05	7	204	3	int:CSHL1
Cytoband	17q24.2	GH1 CSH1 CSH2 CSHL1	1.06e-05	30	210	4	17q24.2
Cytoband	4p13	GRXCR1 ATP8A1 SLC30A9	1.18e-04	21	210	3	4p13
Cytoband	Ensembl 112 genes in cytogenetic band chr17q23	GH1 MED13 CSH1 CSH2 CSHL1	2.38e-04	120	210	5	chr17q23
Cytoband	20q13.2	PFDN4 SALL4 FAM210B	2.54e-04	27	210	3	20q13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr4p13	GRXCR1 ATP8A1 SLC30A9	3.86e-04	31	210	3	chr4p13
Cytoband	2p23.1	OTOF GALNT14	5.73e-04	8	210	2	2p23.1
GeneFamily	Growth hormone family	GH1 CSH1 CSH2 CSHL1	5.10e-08	6	140	4	1175
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MYOM1 LRIG2 IGSF10 SEMA3C FLT1 SDK2 ADAMTSL3 HMCN1 IGSF9B	4.56e-06	161	140	9	593
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	NBN BRCA1	5.86e-04	5	140	2	1336
GeneFamily	Alpha arrestins	ARRDC4 TXNIP	8.75e-04	6	140	2	1311
GeneFamily	Topoisomerases	TOP1MT TOP1	8.75e-04	6	140	2	1050
GeneFamily	Structural maintenance of chromosomes proteins\|Cohesin complex	SMC1A SMC1B	1.22e-03	7	140	2	761
GeneFamily	Schlafen family	SLFN12 SLFN13	1.22e-03	7	140	2	1110
GeneFamily	Transient receptor potential cation channels	TRPM6 TRPM1 MCOLN2	1.29e-03	28	140	3	249
GeneFamily	Ring finger proteins\|Baculoviral IAP repeat containing\|Caspase recruitment domain containing	BIRC6 BIRC2	1.62e-03	8	140	2	419
GeneFamily	Cohesin complex	SMC1A SMC1B	1.62e-03	8	140	2	1060
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B	2.07e-03	9	140	2	1234
Coexpression	GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	ATP6V0A1 STRIP2 IGSF10 IL4I1 FLNB MACC1 LCP1 ADAMTSL3 VIRMA MTOR SLFN13	6.02e-07	199	208	11	M9846
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	NBN PTPRA DST MDN1 BRCA1 NUAK1 PRRC2C BUB1B CCSER2 MED13 PMS1 EHBP1 FLNB SEMA3C USP24 ATP2B1	1.10e-06	466	208	16	M13522
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	VPS13C SMC1A BIRC6 ATP8A1 BRCA1 SRGAP3 PRRC2C MED13 USP24 PRPF8	1.89e-06	180	208	10	M8239
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ZFYVE16 NBN PTPRA DST MDN1 BRCA1 NUAK1 PRRC2C BUB1B CCSER2 MED13 NPAT PMS1 EHBP1 FLNB SEMA3C SUPT20H USP24 THOC2 ATP2B1 TOP1	5.09e-06	856	208	21	M4500
Coexpression	GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN	ATP6V0A1 ARMCX1 DST ATP8A1 CD99L2 RAPSN MID2 ARRDC4 TFRC	1.06e-05	173	208	9	M8909
Coexpression	KAUFFMANN_DNA_REPAIR_GENES	SMC1A NBN BRCA1 REV1 PMS1 MSH4 MTOR SUPT16H TOP1 SMC1B	1.64e-05	230	208	10	M11563
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	GJA8 GPC3 NUAK1 MYLK4 UGDH FAT4 NEBL HTRA3 EDNRA FAM210B	1.54e-08	182	208	10	ceb37c214662a48efb56ab0d015977c6fab478b0
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	ALDH1L1 IGSF10 DST GPC3 NUAK1 LAMA4 ADAMTSL3 EDNRA HMCN1 RANBP3L	2.96e-08	195	208	10	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|367C / Donor, Lineage, Cell class and subclass (all cells)	ATP8A2 IGSF10 DST GPC3 NEBL LAMA4 HTRA3 EDNRA GSTM3 HMCN1	3.42e-08	198	208	10	a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	ATP8A2 IGSF10 DST GPC3 NEBL LAMA4 HTRA3 EDNRA GSTM3 HMCN1	3.42e-08	198	208	10	7b5350768f306ec528e271d2ac4470bf668ec6f0
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C TRIP11 IGSF10 PRRC2C SUPT20H HTRA3 HMCN1 XIRP2 SUPT16H	1.51e-07	176	208	9	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DST GPC3 NUAK1 FAT4 LAMA4 ADAMTSL3 EDNRA HMCN1 RANBP3L	3.02e-07	191	208	9	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	ERBB4 CAPN8 ATP8A1 MTUS1 CFAP221 UNC13B RAP1GAP NEBL ARMC9	3.16e-07	192	208	9	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	DST GPC3 NUAK1 MCOLN2 SDK2 NEBL EDNRA HMCN1 RANBP3L	3.30e-07	193	208	9	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	368C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ATP8A2 DST GPC3 NUAK1 MCOLN2 NEBL LAMA4 EDNRA HMCN1	3.45e-07	194	208	9	d9eec28fa7b255c0ec023276dd955f1e276e7159
ToppCell	368C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ATP8A2 DST GPC3 NUAK1 MCOLN2 NEBL LAMA4 EDNRA HMCN1	3.45e-07	194	208	9	e4d7e9709ce42d4610e44d3445927eefbcbb9eff
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-G\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	ATP8A2 IGSF10 DST GPC3 NUAK1 MCOLN2 NEBL LCP1 EDNRA	3.92e-07	197	208	9	a21a710c824f9e5c7ef1674168d1ce5aef85bd35
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	IGSF10 DST GPC3 NUAK1 MCOLN2 SDK2 SYNE1 LAMA4 EDNRA	4.27e-07	199	208	9	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	IGSF10 DST GPC3 NUAK1 MCOLN2 SDK2 SYNE1 LAMA4 EDNRA	4.27e-07	199	208	9	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	343B-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ATP8A2 IGSF10 DST GPC3 NUAK1 MCOLN2 NEBL LAMA4 EDNRA	4.27e-07	199	208	9	212e89d097753790061310373a1fafba773488b6
ToppCell	343B-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ATP8A2 IGSF10 DST GPC3 NUAK1 MCOLN2 NEBL LAMA4 EDNRA	4.27e-07	199	208	9	14b676aa289c0578a37be32cec3ea285c79d97cc
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	IGSF10 DST GPC3 FAT4 SDK2 LAMA4 EDNRA HMCN1 RANBP3L	4.45e-07	200	208	9	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGSF10 DST GPC3 FAT4 SDK2 LAMA4 EDNRA HMCN1 RANBP3L	4.45e-07	200	208	9	a510deaada669e690329183e18df02870bd204b3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DST GPC3 NUAK1 MCOLN2 LAMA4 ADAMTSL3 EDNRA HMCN1 RANBP3L	4.45e-07	200	208	9	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	NUAK1 FAT4 SYNE1 USP24 OAS2 LCP1 TXNIP SLFN13 NBPF10	4.45e-07	200	208	9	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	IGSF10 DST GPC3 MCOLN2 SYNE1 LAMA4 TEX15 EDNRA ATP2B1	4.45e-07	200	208	9	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGSF10 DST GPC3 FAT4 SDK2 LAMA4 EDNRA HMCN1 RANBP3L	4.45e-07	200	208	9	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ERBB4 CAPN8 MTUS1 CFAP221 UNC13B MACC1 NEBL TMEM132D	8.50e-07	159	208	8	e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C SMC1A TRIP11 PRRC2C FLT1 SYNE1 SLFN12 UBXN2A	1.98e-06	178	208	8	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	OTOF BBOX1 GALNT14 NEBL HTRA3 EDNRA SLIT1	2.05e-06	125	208	7	6cd741dd1c7ee6b16437cca7c15c99b5c95603fc
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ERBB4 CAPN8 ATP8A1 MTUS1 CFAP221 UNC13B MACC1 TMEM132D	2.75e-06	186	208	8	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DST ST8SIA6 MTUS1 SHOC1 PLEKHA8 SEMA3C ARRDC4 TXNIP	2.75e-06	186	208	8	a6ef5d5944af5689b5f27bef89cd05645eedbe50
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ERBB4 CAPN8 ATP8A1 MTUS1 CFAP221 UNC13B RAP1GAP NEBL	2.86e-06	187	208	8	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	DST GPC3 NUAK1 LAMA4 ADAMTSL3 EDNRA HMCN1 RANBP3L	2.86e-06	187	208	8	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	ERBB4 CAPN8 MTUS1 SRGAP3 SERPINB3 NHS FLNB MACC1	3.10e-06	189	208	8	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	ERBB4 CAPN8 MTUS1 SRGAP3 SERPINB3 NHS GALNT14 MACC1	3.22e-06	190	208	8	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	IGSF10 GPC3 SEMA3C LAMA4 HTRA3 ADAMTSL3 EDNRA HMCN1	3.35e-06	191	208	8	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	IGSF10 GPC3 SEMA3C LAMA4 HTRA3 ADAMTSL3 EDNRA HMCN1	3.35e-06	191	208	8	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KLHL24 ERBB4 ATP8A1 MTUS1 CFAP221 UNC13B MACC1 NEBL	3.48e-06	192	208	8	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERBB4 CAPN8 ATP8A1 MTUS1 CFAP221 RAP1GAP NEBL ARMC9	3.48e-06	192	208	8	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DST GPC3 NUAK1 LAMA4 ADAMTSL3 EDNRA HMCN1 RANBP3L	3.48e-06	192	208	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DST GPC3 NUAK1 SDK2 LAMA4 ADAMTSL3 EDNRA HMCN1	3.62e-06	193	208	8	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	ERBB4 CAPN8 ATP8A1 MTUS1 CFAP221 UNC13B NEBL ARMC9	3.62e-06	193	208	8	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	DST GPC3 NUAK1 FAT4 SDK2 LAMA4 EDNRA HMCN1	3.62e-06	193	208	8	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DST GPC3 NUAK1 NEBL LAMA4 EDNRA HMCN1 RANBP3L	3.76e-06	194	208	8	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C TRIP11 DST PTPRN2 PRRC2C KIF5B MGA ATP2B1	3.90e-06	195	208	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	DST GPC3 NUAK1 MCOLN2 LAMA4 EDNRA HMCN1 RANBP3L	3.90e-06	195	208	8	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IGSF10 DST GPC3 NUAK1 LAMA4 ADAMTSL3 EDNRA HMCN1	4.05e-06	196	208	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 DST MTUS1 FLNB IL31RA EDNRA TXNIP HMCN1	4.05e-06	196	208	8	90edf61116ffcb4f8b6be3d0a05732d59b0a87d5
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	UGDH SDK2 NEBL LAMA4 HTRA3 EDNRA GSTM3 FAM210B	4.05e-06	196	208	8	028a06ed92f1c058dcbeacd335625bf529e87a7b
ToppCell	facs-Skin-Telogen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 DST MTUS1 FLNB IL31RA EDNRA TXNIP HMCN1	4.05e-06	196	208	8	c936014125b2ed5f796221b74acb77b8f8359875
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SRGAP3 CFAP221 NHS GALNT14 MACC1 NEBL RHPN2	4.05e-06	196	208	8	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	IGSF10 DST GPC3 NHS TOP1MT SDK2 SYNE1 LAMA4	4.21e-06	197	208	8	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Biopsy_Other_PF-Epithelial-MUC5AC+_High\|Biopsy_Other_PF / Sample group, Lineage and Cell type	ALDH1L1 SERPINB3 SHOC1 BBOX1 GALNT14 BEND5 SALL4 APOB	4.37e-06	198	208	8	30e6177e216f66caddcd009fafef0e07369f4d8e
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DST GPC3 NHS FAT4 LAMA4 ADAMTSL3 EDNRA HMCN1	4.37e-06	198	208	8	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	ATP8A2 DST GPC3 NUAK1 MCOLN2 NEBL EDNRA HMCN1	4.37e-06	198	208	8	e0e47cf65774191981840b22905b2094b95abe0f
ToppCell	(5)_Fibroblast-G\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGSF10 DST GPC3 LAMA4 EDNRA GSTM3 HMCN1 SLIT1	4.53e-06	199	208	8	b4a737575be9f8c65771832dd8cd25328d5dae0d
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DST GPC3 NUAK1 MCOLN2 LAMA4 ADAMTSL3 EDNRA HMCN1	4.70e-06	200	208	8	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBB4 RGSL1 SLC17A3 OXGR1 UNC93A OTOGL MYLK4	5.49e-06	145	208	7	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EML6 ST8SIA6 SRGAP3 SHOC1 SEMA3C APOB GOLGA8H	5.75e-06	146	208	7	e887e9de895fd453faa703997ef372cc6410fc49
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CCDC168 ZNF114 SYNE1 LCP1 TXNIP XIRP2 SLFN13	1.00e-05	159	208	7	bf8ff9251bcb64b2b9d6dd93461aec97659686ec
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERBB4 CAPN8 ATP8A1 MTUS1 ARHGAP8 NEBL TMEM132D	1.00e-05	159	208	7	8680b054622f573a82b1625fb93c2d5db81d1034
ToppCell	356C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ATP8A2 ZNF594 DST GPC3 MCOLN2 NEBL EDNRA	1.05e-05	160	208	7	0293b244c063a62819690bf22bbc2681f8d15252
ToppCell	356C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ATP8A2 ZNF594 DST GPC3 MCOLN2 NEBL EDNRA	1.05e-05	160	208	7	3eaae86fa08f7651021316f8e5811bf48055591e
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ERBB4 RGSL1 SLC17A3 OXGR1 UNC93A OTOGL MYLK4	1.13e-05	162	208	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 ADAMDEC1 EHBP1 MSH4 HMCN1 CST6	1.52e-05	113	208	6	ec4b89e727e1b921b9cb17443774955b95814dd4
ToppCell	droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPC3 ST8SIA6 PTPRN2 IL4I1 SEMA3C BEND5 ADAMTSL3	1.61e-05	171	208	7	20ac3de9c164b409b70a30a8b6544ea491ef7c0e
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST8SIA6 LRRTM4 ARHGAP8 UNC13B TMTC4 RHPN2 CST6	1.80e-05	174	208	7	cdfc50e5383c8670ce5109736aff36406f46c03d
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM6 GUCD1 UGDH PLEKHA8 SEMA3C APOB ATP2B1	1.94e-05	176	208	7	7622f5a8e7320cc7b593141854107ecaf4adff7f
ToppCell	LPS-IL1RA-Myeloid-Myeloid_granulocytic\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC17A3 NBN CAPN8 GPC3 LCP1 IGSF9B	1.95e-05	118	208	6	811e8521129914eef46785a4227c1860e77d9096
ToppCell	LPS-IL1RA-Myeloid-Myeloid_granulocytic-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC17A3 NBN CAPN8 GPC3 LCP1 IGSF9B	1.95e-05	118	208	6	6053e19d040fb394f9c270361af07b0c5a4d47db
ToppCell	droplet-Liver-LIVER-NPC-1m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC26A4 STRIP2 UGDH SCP2 BBOX1 GSTM3 HACD1	2.01e-05	177	208	7	1b077084b78e62ead603f72c9db6ce74a3953f81
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5\|TCGA-Skin / Sample_Type by Project: Shred V9	NHS FLT1 IL31RA LAMA4 FAM135B EDNRA ATP2B1	2.09e-05	178	208	7	ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM6 MYOM1 OXSM ARHGAP8 MACC1 RAPSN GRAMD2A	2.16e-05	179	208	7	88dbec952507d84b85b08165eec80df99ed1e736
ToppCell	facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM6 MYOM1 OXSM ARHGAP8 MACC1 RAPSN GRAMD2A	2.16e-05	179	208	7	daf8189a22786171e2b629261cf720736aa4ebdb
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 GPC3 NUAK1 LRRTM4 MCOLN2 SDK2 NEBL	2.24e-05	180	208	7	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 GPC3 NUAK1 LRRTM4 MCOLN2 SDK2 NEBL	2.24e-05	180	208	7	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SLC17A3 ALDH1L1 NHS BBOX1 GALNT14 MACC1 RHPN2	2.24e-05	180	208	7	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	ERBB4 CAPN8 ATP8A1 MTUS1 CFAP221 UNC13B SYNE1	2.24e-05	180	208	7	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IGSF10 GPC3 NUAK1 LAMA4 EDNRA HMCN1 RANBP3L	2.32e-05	181	208	7	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	COVID-19_Mild-Neu_3\|World / 5 Neutrophil clusters in COVID-19 patients	CCDC168 CFAP221 SDK2 APOB ARMC9 HMCN1	2.35e-05	122	208	6	2aa9cfadab70312882ae679e3788fc7ab996c0f3
ToppCell	Basal\|World / shred by cell class for mouse tongue	KLHL24 DST UGDH SEMA3C RAPSN TXNIP SLIT1	2.49e-05	183	208	7	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARMCX1 DST NUAK1 FLNB FAT4 FLT1 ATP2B1	2.49e-05	183	208	7	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPN8 OTOGL FAT4 SALL4 APOB HMCN1 XIRP2	2.58e-05	184	208	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPN8 OTOGL FAT4 SALL4 APOB HMCN1 XIRP2	2.58e-05	184	208	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERBB4 CAPN8 ATP8A1 MTUS1 CFAP221 NEBL TMEM132D	2.58e-05	184	208	7	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPN8 OTOGL FAT4 SALL4 APOB HMCN1 XIRP2	2.58e-05	184	208	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERBB4 CAPN8 ATP8A1 MTUS1 UNC13B NEBL TMEM132D	2.67e-05	185	208	7	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLC17A3 ST8SIA6 NUAK1 FLNB FAT4 FLT1 HMCN1	2.67e-05	185	208	7	a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAK16 GPC3 UGDH RIOK1 LAMA4 GSTM3 CTPS1	2.67e-05	185	208	7	9878392d79734ab5bb977d7f4f5e2e079b9a5353
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	RUSC2 MACC1 LAMA4 HTRA3 SALL4 EDNRA TMTC4	2.96e-05	188	208	7	14bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ERBB4 CAPN8 MTUS1 CFAP221 ARHGAP8 UNC13B NEBL	2.96e-05	188	208	7	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	facs-MAT-Fat-3m\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RUSC2 IGSF10 GPC3 SEMA3C PRPF8 EDNRA TXNIP	2.96e-05	188	208	7	7da9750255efbc5cf9aed7e3105a337fac63b9f0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 CAPN8 DST CFAP221 NHS BBOX1 MACC1	3.06e-05	189	208	7	aadb7a2de4cbe7f0958651f2739bba430b93f5c1
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	IGSF10 DST GPC3 SRGAP3 LAMA4 HMCN1 SLIT1	3.06e-05	189	208	7	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 CAPN8 DST CFAP221 NHS BBOX1 MACC1	3.06e-05	189	208	7	8977f3295b7df7c7474b3f371de90a82ae4bb50c
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IGSF10 GPC3 C4B NEBL LAMA4 HTRA3 EDNRA	3.06e-05	189	208	7	e76dc36a01d8ad7590b3acc4c46abfcb76857448
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-Mesoderm\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	MCM8 APOB GRAMD2A XIRP2	3.22e-05	39	208	4	3479d255b87fa8042c51d80a3eb81a774850132e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C TRIP11 PRRC2C KIF5B APOB SENP6 UBXN2A	3.28e-05	191	208	7	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERBB4 CAPN8 ATP8A1 MTUS1 CFAP221 UNC13B NEBL	3.28e-05	191	208	7	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOM1 STRIP2 MYLK4 EHBP1 NEBL TFRC XIRP2	3.28e-05	191	208	7	97fb4232417a39801e87725755fd16a57c250209
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERBB4 CAPN8 ATP8A1 MTUS1 CFAP221 UNC13B NEBL	3.28e-05	191	208	7	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C TRIP11 PRRC2C KIF5B APOB SENP6 UBXN2A	3.28e-05	191	208	7	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOM1 STRIP2 MYLK4 EHBP1 NEBL TFRC XIRP2	3.28e-05	191	208	7	64070a309d7e3f6001272409ab9ce206d0e7d73f
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C TRIP11 PRRC2C KIF5B APOB SENP6 UBXN2A	3.28e-05	191	208	7	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	ERBB4 CAPN8 ATP8A1 MTUS1 CFAP221 UNC13B NEBL	3.39e-05	192	208	7	499e8893afea5e6d3371e0bd018f7e86a524d669
Drug	mesyl chloride	NBN FLT1 SYNE1 GUSB	2.08e-06	11	207	4	CID000031297
Disease	Malignant neoplasm of breast	ERBB4 NBN COG3 BRCA1 OTOF OTOGL SRGAP3 SCP2 NHS OXSM HERC2 ANAPC5 PLEKHA8 EHBP1 FLNB FLT1 RAP1GAP SYNE1 FRMPD1 BIRC2 EDNRA ZNF546 TFRC TMTC4 MTOR CST6 TOP1	7.56e-09	1074	204	27	C0006142
Disease	isolated growth hormone deficiency type II (implicated_via_orthology)	GH1 CSH1 CSH2 CSHL1	1.10e-08	5	204	4	DOID:0060872 (implicated_via_orthology)
Disease	isolated growth hormone deficiency (implicated_via_orthology)	GH1 CSH1 CSH2 CSHL1	7.64e-08	7	204	4	DOID:0060870 (implicated_via_orthology)
Disease	fatty acid measurement, fetal genotype effect measurement, breast milk measurement	ATP8A2 COG3 RAPSN FAM135B	1.51e-06	13	204	4	EFO_0005110, EFO_0007959, EFO_0009092
Disease	congenital hypothyroidism (biomarker_via_orthology)	GH1 CSH1 CSH2 CSHL1	2.10e-06	14	204	4	DOID:0050328 (biomarker_via_orthology)
Disease	fatty acid measurement, breast milk measurement, parental genotype effect measurement	ATP8A2 COG3 RAPSN FAM135B	2.10e-06	14	204	4	EFO_0005110, EFO_0005939, EFO_0009092
Disease	type 1 diabetes mellitus (implicated_via_orthology)	GH1 PTPRN2 CSH1 CSH2 CSHL1	7.15e-06	39	204	5	DOID:9744 (implicated_via_orthology)
Disease	osteoporosis (biomarker_via_orthology)	GH1 CSH1 CSH2 CSHL1	1.47e-05	22	204	4	DOID:11476 (biomarker_via_orthology)
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	ANKRD31 RAPSN APOB LCP1 ATP2B1	2.73e-05	51	204	5	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	biliary tract cancer (is_marker_for)	APOB PPARD	4.76e-05	2	204	2	DOID:4607 (is_marker_for)
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	SMC1A GH1 EDNRA CSH1 CSH2 CSHL1 MTOR	7.66e-05	147	204	7	DOID:9352 (biomarker_via_orthology)
Disease	Vasodilators used in cardiac diseases use measurement	FLT1 APOB EDNRA ATP2B1	8.74e-05	34	204	4	EFO_0009926
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	ANKRD31 RAPSN APOB LCP1 ATP2B1	1.18e-04	69	204	5	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	Thyroid Hypoplasia	SLC26A4 TSHR	1.42e-04	3	204	2	C0151516
Disease	phosphatidylcholine 38:6 measurement	PTPRA RAPSN TMTC4	1.71e-04	16	204	3	EFO_0010388
Disease	triacylglycerol 54:4 measurement	ATP8A2 RAPSN APOB LCP1	2.88e-04	46	204	4	EFO_0010422
Disease	melanoma	ERBB4 CUL3 FAT4 FLT1 RAP1GAP PPARD CST6 KDM4A	3.50e-04	248	204	8	C0025202
Disease	Uterine leiomyoma	MCM8 ZNF208 NPAT REV1 SYNE1	4.32e-04	91	204	5	HP_0000131
Disease	proprotein convertase subtilisin/kexin type 9 measurement	RAPSN USP24 APOB	4.55e-04	22	204	3	EFO_0009312
Disease	Thyroid Agenesis	SLC26A4 TSHR	4.69e-04	5	204	2	C0749420
Disease	free cholesterol to total lipids in small LDL percentage	RAPSN APOB LCP1 TGDS	4.98e-04	53	204	4	EFO_0022286
Disease	stomach carcinoma (is_marker_for)	ERBB4 BRCA1 KDM4A	5.92e-04	24	204	3	DOID:5517 (is_marker_for)
Disease	ovarian cancer (is_implicated_in)	NBN BRCA1 APOB TFRC	6.15e-04	56	204	4	DOID:2394 (is_implicated_in)
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	RAPSN APOB LCP1 TGDS	6.15e-04	56	204	4	EFO_0022316
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	RAPSN APOB LCP1 TGDS	7.50e-04	59	204	4	EFO_0022260
Disease	triacylglycerol 56:5 measurement	ZNF836 RAPSN LCP1	7.53e-04	26	204	3	EFO_0010432
Disease	level of Sterol ester (27:1/16:0) in blood serum	RAPSN USP24 APOB	7.53e-04	26	204	3	OBA_2045191
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	RAPSN APOB LCP1 TGDS	7.99e-04	60	204	4	EFO_0021898
Disease	cholesterol to total lipids in small LDL percentage	ANKRD31 APOB LCP1	8.43e-04	27	204	3	EFO_0022241
Disease	cholesterol to total lipids in medium LDL percentage	ANKRD31 APOB LCP1	8.43e-04	27	204	3	EFO_0022238
Disease	free cholesterol in very large VLDL measurement	ANKRD31 RAPSN APOB LCP1	8.51e-04	61	204	4	EFO_0022274
Disease	total lipids in chylomicrons and extremely large VLDL measurement	RAPSN APOB LCP1 TGDS	9.04e-04	62	204	4	EFO_0022306
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	RAPSN APOB LCP1 TGDS	9.04e-04	62	204	4	EFO_0022263
Disease	remnant cholesterol measurement	ANKRD31 EHBP1 APOB LCP1 TOP1	9.42e-04	108	204	5	EFO_0010815
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	FLT1 APOB LCP1 ATP2B1	9.61e-04	63	204	4	EFO_0001645, EFO_0004792
Disease	free cholesterol to total lipids in medium LDL percentage	RAPSN APOB LCP1 TGDS	9.61e-04	63	204	4	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	RAPSN APOB LCP1 TGDS	9.61e-04	63	204	4	EFO_0022292
Disease	quality of life during menstruation measurement, Stiff neck	LRRTM4 SEMA3C	9.76e-04	7	204	2	EFO_0009366, HP_0025258
Disease	epidermolysis bullosa simplex (is_implicated_in)	KLHL24 DST	9.76e-04	7	204	2	DOID:4644 (is_implicated_in)
Disease	carcinoma (implicated_via_orthology)	ERBB4 FAT4 FLT1 SALL4	1.02e-03	64	204	4	DOID:305 (implicated_via_orthology)
Disease	coronary artery disease, factor VII measurement	FLT1 APOB LCP1 EDNRA ATP2B1	1.07e-03	111	204	5	EFO_0001645, EFO_0004619
Disease	factor VIII measurement, coronary artery disease	FLT1 APOB LCP1 EDNRA ATP2B1	1.15e-03	113	204	5	EFO_0001645, EFO_0004630
Disease	triacylglycerol 54:3 measurement	ATP8A2 RAPSN LCP1	1.27e-03	31	204	3	EFO_0010421
Disease	free cholesterol in large VLDL measurement	ANKRD31 RAPSN APOB LCP1	1.28e-03	68	204	4	EFO_0022265
Disease	von Willebrand factor measurement, coronary artery disease	FLT1 APOB LCP1 EDNRA ATP2B1	1.40e-03	118	204	5	EFO_0001645, EFO_0004629
Disease	tissue plasminogen activator measurement, coronary artery disease	FLT1 APOB LCP1 ATP2B1	1.50e-03	71	204	4	EFO_0001645, EFO_0004791
Disease	free cholesterol to total lipids in small VLDL percentage	ANKRD31 RAPSN APOB LCP1	1.84e-03	75	204	4	EFO_0022287
Disease	cervical cancer (is_marker_for)	ERBB4 MACC1 BIRC2	1.97e-03	36	204	3	DOID:4362 (is_marker_for)
Disease	cholesteryl esters to total lipids in very large HDL percentage	RAPSN APOB LCP1	1.97e-03	36	204	3	EFO_0022257
Disease	Sarcomatoid Renal Cell Carcinoma	FPGT FLT1 APAF1 MTOR AP5M1	2.00e-03	128	204	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	FPGT FLT1 APAF1 MTOR AP5M1	2.00e-03	128	204	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	FPGT FLT1 APAF1 MTOR AP5M1	2.00e-03	128	204	5	C1266044
Disease	esterified cholesterol measurement	ANKRD31 RAPSN APOB LCP1 TOP1	2.00e-03	128	204	5	EFO_0008589
Disease	Papillary Renal Cell Carcinoma	FPGT FLT1 APAF1 MTOR AP5M1	2.00e-03	128	204	5	C1306837
Disease	Renal Cell Carcinoma	FPGT FLT1 APAF1 MTOR AP5M1	2.00e-03	128	204	5	C0007134
Disease	renal cell carcinoma (is_marker_for)	ERBB4 FLT1 BIRC2 TFRC MTOR	2.00e-03	128	204	5	DOID:4450 (is_marker_for)
Disease	level of Triacylglycerol (51:3) in blood serum	APOB LCP1	2.06e-03	10	204	2	OBA_2045163
Disease	oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement	RAPSN LCP1	2.06e-03	10	204	2	EFO_0800333
Disease	tongue squamous cell carcinoma (is_marker_for)	ERBB4 MTUS1 BIRC2	2.13e-03	37	204	3	DOID:0050865 (is_marker_for)
Disease	free cholesterol to total lipids in large VLDL percentage	RAPSN APOB LCP1	2.13e-03	37	204	3	EFO_0022281
Disease	very low density lipoprotein cholesterol measurement	ANKRD31 EHBP1 RAPSN APOB LCP1 TGDS TOP1	2.30e-03	260	204	7	EFO_0008317
Disease	Graves' disease (is_implicated_in)	TSHR C4A C4B	2.48e-03	39	204	3	DOID:12361 (is_implicated_in)
Disease	triglycerides to total lipids in large VLDL percentage	ANKRD31 APOB LCP1	2.48e-03	39	204	3	EFO_0022332
Disease	aspirin use measurement	FLT1 LCP1 EDNRA	2.48e-03	39	204	3	EFO_0007013
Disease	response to radiation, breast carcinoma	PTPRN2 NEBL	2.51e-03	11	204	2	EFO_0000305, GO_0009314
Disease	oleoyl-linoleoyl-glycerol (18:1/18:2) [1] measurement	RAPSN LCP1	2.51e-03	11	204	2	EFO_0800332
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	RAPSN USP24 APOB LCP1 TOP1	2.69e-03	137	204	5	EFO_0004611, EFO_0008591
Disease	Neoplasm of uncertain or unknown behavior of breast	ERBB4 BRCA1 HERC2	2.86e-03	41	204	3	C0496956
Disease	Breast adenocarcinoma	ERBB4 BRCA1 HERC2	2.86e-03	41	204	3	C0858252
Disease	integral membrane protein 2B measurement	APOB LCP1	3.00e-03	12	204	2	EFO_0802634
Disease	body weight	KLHL24 ERBB4 VPS13C GH1 RBM19 ARHGAP8 MGA UNC13B EHBP1 RAPSN ADAMTSL3 VIRMA CSH2 MTOR GUSB SLIT1 SENP6 XPO7	3.02e-03	1261	204	18	EFO_0004338
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	ANKRD31 RAPSN APOB LCP1	3.03e-03	86	204	4	EFO_0008595, EFO_0020945
Disease	cholesteryl esters to total lipids in small LDL percentage	RAPSN APOB LCP1	3.07e-03	42	204	3	EFO_0022255
Disease	initial pursuit acceleration	LRRTM4 MED13 FAM135B TMEM132D	3.16e-03	87	204	4	EFO_0008434
Disease	cognitive impairment measurement	UNC13B RAP1GAP TRAV30	3.50e-03	44	204	3	EFO_0007998
Disease	Thyroid carcinoma	TSHR RAP1GAP MTOR	3.50e-03	44	204	3	C0549473
Disease	sleep duration, low density lipoprotein cholesterol measurement	ANKRD31 RAPSN USP24 APOB	3.71e-03	91	204	4	EFO_0004611, EFO_0005271
Disease	cholesterol to total lipids in large VLDL percentage	ANKRD31 APOB LCP1	3.73e-03	45	204	3	EFO_0022236
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	FPGT FLT1 APAF1 MTOR AP5M1	3.74e-03	148	204	5	C0279702
Disease	cleft lip	ATP8A2 CCDC168 DST BRCA1 EHBP1 SYNE1 TMEM132D	3.75e-03	284	204	7	EFO_0003959
Disease	Prostatic Neoplasms	SLC26A4 NBN GUCD1 BRCA1 MGA PMS1 CUL3 EHBP1 GSTM3 CST6 SENP6	3.91e-03	616	204	11	C0033578
Disease	Malignant neoplasm of prostate	SLC26A4 NBN GUCD1 BRCA1 MGA PMS1 CUL3 EHBP1 GSTM3 CST6 SENP6	3.91e-03	616	204	11	C0376358
Disease	obesity (implicated_via_orthology)	CAPN8 SCP2 MED13 FAT4 SDK2 GSTM3	3.93e-03	215	204	6	DOID:9970 (implicated_via_orthology)
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	EHBP1 RAPSN APOB LCP1 TGDS TOP1	3.93e-03	215	204	6	EFO_0008317, EFO_0008591
Disease	response to hydrochlorothiazide, fasting blood glucose measurement	OTOGL ARMC9 NIPAL2	3.97e-03	46	204	3	EFO_0004465, EFO_0005202
Disease	actinic keratosis	MMP24 HERC2	4.10e-03	14	204	2	EFO_0002496
Disease	vascular dementia (biomarker_via_orthology)	FLT1 MTOR	4.10e-03	14	204	2	DOID:8725 (biomarker_via_orthology)
Disease	Hereditary Breast and Ovarian Cancer Syndrome	NBN BRCA1	4.10e-03	14	204	2	C0677776
Disease	free cholesterol in small VLDL measurement	RAPSN APOB LCP1	4.22e-03	47	204	3	EFO_0022272
Disease	free cholesterol in medium VLDL measurement	RAPSN APOB LCP1	4.22e-03	47	204	3	EFO_0022269
Disease	low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	ANKRD31 RAPSN APOB LCP1 TGDS	4.31e-03	153	204	5	EFO_0004611, EFO_0020944
Disease	Squamous cell carcinoma of esophagus	SERPINB3 BUB1B FAT4 SALL4	4.33e-03	95	204	4	C0279626
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	RAPSN APOB LCP1 TGDS	4.33e-03	95	204	4	EFO_0004529, EFO_0008317, EFO_0008596
Disease	sexual dimorphism measurement	ANKRD31 TRIP11 GH1 MMP24 MGA RAPSN APOB PPARD MLXIP LCP1 ADAMTSL3 CSH1 CSHL1 SLIT1 CST6 CTPS1	4.49e-03	1106	204	16	EFO_0021796
Disease	chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement	RAPSN APOB LCP1 TGDS	4.49e-03	96	204	4	EFO_0004530, EFO_0008317, EFO_0008596
Disease	low density lipoprotein triglyceride measurement	APOB LCP1	4.71e-03	15	204	2	EFO_0009946
Disease	hepatoblastoma (is_marker_for)	GPC3 SALL4	4.71e-03	15	204	2	DOID:687 (is_marker_for)
Disease	triacylglycerol 52:3 measurement	APOB LCP1	4.71e-03	15	204	2	EFO_0010415
Disease	phosphatidylcholine 36:3 measurement	RAPSN TMEM132D	4.71e-03	15	204	2	EFO_0010381
Disease	level of Triacylglycerol (53:3) in blood serum	RAPSN LCP1	4.71e-03	15	204	2	OBA_2045165

Protein segments in the cluster

Peptide	Gene	Start	Entry
QVTQGDSKYTKNLAV	BEND5	316	Q7L4P6
NKNNQALKIVDFSYS	BUB1B	901	O60566
QTFYTNGTNLKKIHV	APAF1	1211	O14727
QFQSLKEISAGNIYI	ERBB4	446	Q15303
TFANTLGKAEYLKNN	ERBB4	1211	Q15303
IQSNKGSSYKLLVEQ	BIRC6	2261	Q9NR09
NSSTQFEVKKYVLPN	C4B	226	P0C0L5
TKSAYNQKVDLFSLG	EIF2AK4	916	Q9P2K8
SSLNQSYKFCQGKLQ	TBC1D32	161	Q96NH3
NATTGEIFNKQILKY	FAT4	2921	Q6V0I7
KQIGYLFISVLVNSN	AP2A1	91	O95782
TGQTLKQTYSKFDTN	CSHL1	166	Q14406
QQTKITSAFKYINTV	EDNRA	71	P25101
GLKKIFYIVNQKNTS	ANGPTL5	226	Q86XS5
NQNALKYLGQDFKTL	CAPN8	21	A6NHC0
NNSVAYSGVKNSLKE	ATP2B1	6	P20020
LYKTSQNALDFNTKV	ATP8A1	926	Q9Y2Q0
LYKITQNGEGFNTKV	ATP8A2	946	Q9NTI2
KQIGYLFISVLVNSN	AP2A2	91	O94973
AIFQTQTYLASGKTK	ARRDC4	231	Q8NCT1
LVSYLKQKQAAGVIS	RBM15	891	Q96T37
DAIAQKYNATKSQVF	RBM19	526	Q9Y4C8
EKGLQLYQSNQTEKA	RAPSN	11	Q13702
IKGLVYSSNFQNVKQ	NSUN5	21	Q96P11
NVKSQTYSKDLLGQQ	PTPRN2	446	Q92932
NTQTEQKLSGKLYLV	KIF5B	216	P33176
LFDYGKTKNNKNISQ	NPAT	331	Q14207
TALQQYFQNGEKKTV	ANAPC5	156	Q9UJX4
SGQQDTIKKALNYST	ANKRD31	1676	Q8N7Z5
SETALNFQTKGYNKV	OXSM	161	Q9NWU1
NLGKTIDNKALYNIF	PABPC1L2A	96	Q5JQF8
LVLVYTIFQFKNKTG	MMP24	616	Q9Y5R2
YIISSLKQQVGSSKQ	SLC17A3	191	O00476
LISNFSKVSGYKINV	nan	721	O00370
SKVSGYKINVQKSQA	nan	726	O00370
VDYLKGLSVNKNTVQ	MDN1	921	Q9NU22
LANSQYATIKEEKGQ	MAK16	46	Q9BXY0
SYNKLQTLQSEQFKG	LRRTM4	141	Q86VH4
QSSNYLKQSKTLFTN	LRIF1	461	Q5T3J3
YIEANSISNSKGQKT	MCM8	356	Q9UJA3
YKVSAGQALFNNLTK	GRXCR1	111	A8MXD5
FYKLKLTNNTLDQEG	MGA	176	Q8IWI9
KGFSKTVNSSILQYG	IL31RA	466	Q8NI17
TQYKTKCENQSGFIL	MTUS1	906	Q9ULD2
IQYVQKNAGKLTTTI	GPC3	331	P51654
KVYDIKDFQTQSLTG	HERC2	1231	O95714
KQVKTLQESYNLLFS	DST	1516	Q03001
FTKLNSYIQGKNEKE	HEBP2	66	Q9Y5Z4
LTIYKENGQSNKEIL	ARMC9	196	Q7Z3E5
FVSKSVSKILNYDQA	ARNTL2	206	Q8WYA1
TGQILKQTYSKFDTN	CSH2	161	P0DML3
QQYKTAEFLSKLNTE	EPSTI1	186	Q96J88
TKAEVSIQNNKDGTY	FLNB	1176	O75369
KVQLYAKFGSNINLE	PFDN4	116	Q9NQP4
NYAVELGKNQAKFSL	LCP1	461	P13796
FQLNKYTGEIKISEN	PCDHGA10	296	Q9Y5H3
SKNATVGQSVLNIKY	PEX2	71	P28328
VGQSVLNIKYKNDFS	PEX2	76	P28328
SQQLKKIFQEYGTVG	FAM210B	86	Q96KR6
KQGAVNSFYTVSKTE	MYLK4	96	Q86YV6
SNIIQFKYFIKSENG	KCTD4	191	Q8WVF5
TGQSGLFTQYNIQKK	KDM4A	76	O75164
SGVAQKNYFNILDKI	FBXO25	141	Q8TCJ0
YLLDGKNKITQSNAI	GSTM3	66	P21266
FLYSGQKNDSELNTK	AP5M1	141	Q9H0R1
EKDIQTALNNAYGKT	PLEKHA8	426	Q96JA3
QKSLDGFTIQVFTKN	OAS2	121	P29728
ENTAGSAKKYFNLNV	HMCN1	2946	Q96RW7
GNANTYIKNTKRTAE	GALNT14	346	Q96FL9
VSGNLEQAKKISYSN	OXGR1	321	Q96P68
TVNKQTCQTYSFGKT	MLXIP	101	Q9HAP2
ELDAQYLQNTFKVSK	BRCA1	851	P38398
VNLLGTSKNSNVKSY	CCSER2	36	Q9H7U1
TQTLGVDKGYKNQSF	GUCD1	86	Q96NT3
QSGIIKNTASLKYEN	APOB	1551	P04114
KINNQLTLDSNTKYF	APOB	2876	P04114
KVQLQNGDSYEATIK	HTRA3	206	P83110
YQSSRDKKVLNNGTL	IGSF10	616	Q6WRI0
TGKVKITTENVQYLF	KLHL24	126	Q6TFL4
ISYQQKKFCFSIQQG	CD99L2	206	Q8TCZ2
QKNDSQLVIEAYKSG	FNBP1	261	Q96RU3
ESLQKQYLFVSNKTG	COG3	156	Q96JB2
NVLKLYLENGQTKAF	FRMPD1	181	Q5SYB0
AVSSIQKAKGYQLLE	GJA8	256	P48165
SQKFLAENSASVYIK	CUL3	221	Q13618
YQISVKGSNLFKLEV	GUSB	246	P08236
NQYSAKSGEVLVNVK	EIF3I	171	Q13347
GLYKSIQKTLKFFQT	HACD1	106	B0YJ81
KIDANNVAYTTGKLS	BBOX1	186	O75936
QIEENSSKSTYKVGN	EHBP1	556	Q8NDI1
KTLNFSNYGVTLKAV	MACC1	546	Q6ZN28
QTLNIQKGKLNTDLY	GOLGA8H	136	P0CJ92
KAQSQLVAGIKYFLT	CST6	76	Q15828
DVQSVFKGKTYNQLQ	CACTIN	401	Q8WUQ7
NYINFSATGKLLVSV	EML6	1466	Q6ZMW3
GYDTKNTRQDNSILK	FAM102B	121	Q5T8I3
FSKSQIYKGNSEKNV	CCDC168	2556	Q8NDH2
LSQKTGLQYFKNVVL	FAM135B	1296	Q49AJ0
NFALKNDKTVNATTY	EQTN	91	Q9NQ60
QSGKVLEYFNNQETK	FAM161A	591	Q3B820
NGLAITTNTSQKYIF	GRAMD2A	146	Q8IUY3
TGQILKQTYSKFDTN	CSH1	161	P0DML2
AENSVKLKNLTGYTA	SDK2	1681	Q58EX2
QDISYLAKGKVANTN	SALL4	166	Q9UJQ4
TKERQSKYNLINEGS	SLFN13	156	Q68D06
TDVLFNKVESSGKNY	PMS1	366	P54277
ITDSYDTIKKFQQNG	MCOLN2	506	Q8IZK6
NSSTQFEVKKYVLPN	C4A	226	P0C0L4
GTSLNVVVLNNSKFY	FPGT	356	O14772
AFKSSAVQQLLEKNY	DIMT1	241	Q9UNQ2
QKQSGFFLENKSTYQ	OTOGL	1021	Q3ZCN5
VFNYSKVFSNKLIGT	OTOF	66	Q9HC10
INASFINGYQEKNKF	PTPRA	296	P18433
KAVKNVQINSIYSFS	LAMA4	1601	Q16363
LGLNLTKFTQYDKNT	IL4I1	131	Q96RQ9
LTDFVSKAYGKNLSQ	NOXRED1	286	Q6NXP6
TLSSLVFQLGKKYQI	MTOR	1176	P42345
KSSEVQIKQSYSFFN	CFAP221	561	Q4G0U5
YEQVKTTLKEGLQNA	MUC3B	1016	Q9H195
QDNILYQTVTGLKKD	RIOK1	461	Q9BRS2
STKVLHGLYNKVSQF	RUSC2	1081	Q8N2Y8
KDIQTALNNAYGKTL	PLEKHA8P1	311	O95397
NFLESKKEYNSIGVS	SLITRK4	761	Q8IW52
TIQKAIKQSFSLGYI	RGSL1	356	A5PLK6
LYGDNIQISASINKK	TDRD6	1141	O60522
AQLQNTYTLKAFTVG	TDRD6	2016	O60522
ISSKKQQLYVSSNEG	SEMA3C	491	Q99985
SQYNPQVADLKAFSK	PPARD	166	Q03181
NTLKETSLYQLQFKE	SPATA22	221	Q8NHS9
KFFNQNILSYITAKN	STRIP2	611	Q9ULQ0
QKIKGYQEQIASLNS	SYNE1	5786	Q8NF91
KYLLSTNSQKSINGQ	TMEM132D	1001	Q14C87
GLIYRNAKKSNTSNE	NHS	1501	Q6T4R5
LTLKDNSKYGTFVNE	NBN	66	O60934
TQLSGFLANQQKKYK	NBPF10	316	Q6P3W6
FQVKFLNQATKLYNT	NIPAL2	261	Q9H841
QSSIYSQTEEKAQGK	SEMG1	311	P04279
SLFNTYKGKSLETQK	PRRC2C	21	Q9Y520
NNFKFGVIYQKLGQT	RAP1GAP	191	P47736
RLTKDNNLTTGKIYQ	CTPS1	81	P17812
SQKITQLRGQESQKY	SHLD1	126	Q8IYI0
QTACNKLYSQKGNLF	SHOC1	1316	Q5VXU9
KLYSQKGNLFTDQQK	SHOC1	1321	Q5VXU9
CKNLQYGIESFSNKT	ST8SIA6	81	P61647
SQFADNTTYAKVITK	MSH4	186	O15457
NFTTIQRKYFNETKG	MSH4	236	O15457
NSLLAKVFITKQGYA	NHEJ1	21	Q9H9Q4
NIKIADFGLSNLYQK	NUAK1	191	O60285
GNNEAFSKLKLYAQV	MED13	1441	Q9UHV7
LASEAFVQKYGLQSK	SCP2	236	P22307
FREGSLVINSKNQYK	SUPT16H	356	Q9Y5B9
KASVLFNTGALYTQI	RHPN2	216	Q8IUC4
YINLDKAVLGTSNFK	TFRC	481	P02786
NTTLVLVNAIYFKGQ	SERPINB3	171	P29508
QTVQSKILTTGENYK	BIRC2	411	Q13490
YKGNILNEKNSVASI	ADAMDEC1	126	O15204
DKLQAGTVFVNTYNK	ALDH1L1	851	O75891
VNAENQGKIKTYISQ	ARMCX1	276	Q9P291
YGKKNNVNVASLTQS	PRPF8	1991	Q6P2Q9
LETISNKQNYKFIQG	TGDS	61	O95455
YDLSGDFQKQTLLKQ	XIRP2	2001	A4UGR9
FSLANVLGKSQKYKE	TMTC4	656	Q5T4D3
IVQNSNGYKIVTEKS	UGDH	116	O60701
FQKSSVVIKQTGIYA	ZFP28	401	Q8NHY6
LQYVANQLKAGKSFD	THOC2	661	Q8NI27
QNIKDSFQKVTLSRY	ZNF138	26	P52744
ASEELKNYSKQFGQL	TRPM6	661	Q9BX84
TKFKEYVNGSNLITK	SRGAP3	441	O43295
LYTKQSSVQKGLSFN	REV1	131	Q9UBZ9
LKIVLNVSTKNYNGV	SLC26A4	236	O43511
TAYQFSVLAQNKLGT	IGSF9B	576	Q9UPX0
TNIGKVSSYIKEQTQ	SMC1B	1161	Q8NDV3
KTNNKISEGNSYLLS	RANBP3L	156	Q86VV4
QYQKTKLTILQSLGD	SUPT20H	346	Q8NEM7
IYLSQLQTGEKSKNT	ZNF546	151	Q86UE3
YSDGASQQFLNSIKK	UBXN2A	81	P68543
TQNNALYGVLFEKSK	UNC93A	366	Q86WB7
ENKQVALGTSKLNYL	TOP1MT	546	Q969P6
ALDNTNIGKVANYIK	SMC1A	1161	Q14683
TGQIFKQTYSKFDTN	GH1	161	P01241
FKGYSTQTALTLKQK	SLFN12	466	Q8IYM2
QNTGLTTKKFYGNNV	SENP6	266	Q9GZR1
SYKQDKNGSQIDAVL	VPS13C	2031	Q709C8
LQSQVGTKTYKQLVA	RRP36	56	Q96EU6
SPDKFNTYVTLKVQN	UNC13B	16	O14795
KASVLFNTGALYTQI	RHPN2P1	131	A8MT19
LQSYIQAKEATAGKN	SNX19	166	Q92543
TQQFGVSLQYLKDKN	ARHGAP8	221	P85298
LVTIQKTFNYNKAQS	TRPM1	311	Q7Z4N2
LKSNLTLVNQSKGYE	ZNF350	136	Q9GZX5
TLVNQSKGYEIKNSV	ZNF350	141	Q9GZX5
KTNKFTYGFQNIVDA	ATP6V0A1	366	Q93050
HKEGYNKLNQSLTTT	ZNF208	126	O43345
IQSYEQNETKLKNFG	TRIP11	1271	Q15643
QIFKNTFQGIYSDQK	USP24	1796	Q9UPU5
QFRKIYIGDQVQKSS	XPO7	556	Q9UIA9
NYVIKLQGESSNSIK	ZNF233	156	A6NK53
ISEFIINNRNYSTKK	ZNF510	186	Q9Y2H8
YEVSGQNFKQKSGLT	ZNF594	101	Q96JF6
LSQVKLYSTNVQKEG	SLC30A9	61	Q6PML9
YQKSQKDISETLGNN	SPZ1	271	Q9BXG8
KLGKINQNYASIITE	TEX15	366	Q9BXT5
LQYTIFTGQANFISK	MID2	436	Q9UJV3
YLANGQTKVLTQKLS	TXNIP	221	Q9H3M7
GNYTILLSIKQSNVF	FLT1	401	P17948
SLYDNKIQSLAKGTF	SLIT1	411	O75093
GKLNSATQKQTESYL	PRPF18	216	Q99633
QGYKTKVTNEVASLF	TRAV4	66	A0A0B4J268
SYLQLKNTKQDSLGQ	VIRMA	416	Q69YN4
NKQIALGTSKLNYLD	TOP1	711	P11387
NKKYDGLQQQLSSVE	TEX9	261	Q8N6V9
SVQTNISKKYENEFL	ZNF836	186	Q6ZNA1
YSGTENLKDKKIFNQ	ZFYVE16	221	Q7Z3T8
SIFKYNPVLNDSQKT	ZNF114	156	Q8NC26
ISASFNEKKQQSSLY	TRAV30	81	A0A087WSZ9
AFNGTKLDAVYLNKN	TSHR	196	P16473
VVKQSYEFSNSNKNL	ZNF302	181	Q9NR11
FLQGHKKYILQATNT	ADAMTSL3	1396	P82987
FGSNYSQKAKLTVNE	LRIG2	586	O94898
AEKLSGNAKVNYIFN	MYOM1	1266	P52179
QNQLAATLASNVKYK	NEBL	256	O76041